Eton Pharmaceuticals (ETON) EV to FCF (2018 - 2025)

Eton Pharmaceuticals has disclosed EV to FCF across 8 years of filings, most recently posting 37.19 for Q4 2025.

• In Q4 2025, EV to FCF rose 91.52% year-over-year to 37.19; the TTM figure through Dec 2025 stood at 42.33 (down 88.29% YoY), while the FY2025 annual figure was 42.33, down 88.29% from the prior year.
• EV to FCF came in at 37.19 for Q4 2025 at Eton Pharmaceuticals, down from 46.47 in the prior quarter.
• In the past five years, EV to FCF ranged from a high of 235.47 in Q4 2023 to a low of 438.65 in Q4 2024.
• Average EV to FCF over 5 years is 6.49, with a median of 19.79 recorded in 2022.
• Year-over-year, EV to FCF slumped 835.29% in 2021 and surged 1106.54% in 2023.
• Over 5 years, EV to FCF stood at 17.82 in 2021, then soared by 209.54% to 19.52 in 2022, then surged by 1106.54% to 235.47 in 2023, then sank by 286.29% to 438.65 in 2024, then jumped by 91.52% to 37.19 in 2025.
• Per Business Quant data, the three most recent EV to FCF figures were 37.19 in Q4 2025, 46.47 in Q3 2025, and 44.83 in Q2 2025.